ChengDu Sheng Nuo Biotec (688117.SH): Subsidiary signs sales contract for GLP-1 peptide active pharmaceutical ingredients worth no more than 350 million yuan.
XINOI Bio (688117.SH) announced that its wholly-owned subsidiary, Chengdu XINOI Bio Pharmaceutical Co., Ltd. ("XINOI...
ChengDu Sheng Nuo Biotec (688117.SH) announced that its wholly-owned subsidiary, ChengDu Sheng Nuo Biotec Pharmaceutical Co., Ltd. ("Sheng Nuo Pharmaceutical"), recently signed a "Product Procurement Contract" with a certain customer to supply GLP-1 peptide bulk drugs to the counterparty. The contract amount is not more than RMB 350 million (including tax).
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
